We are passionate and committed to make our products globally available to enable patients to live and embrace life
WHO WE ARE
We are a dynamic, global speciality pharmaceutical company committed to bringing innovative medicines to patients.
Our therapy areas, which focus on oncology and rare diseases, help make a meaningful difference to patients’ lives.
EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients with COVID-19 Associated Acute Respiratory Distress Syndrome
EUSA Pharma and Papa Giovanni XXIII Hospital, Italy, Provide Interim Analysis Data for Siltuximab-treated COVID-19 Patients from the SISCO Study